Interactions
Organism
Gene Name
| S.No | BIMP ID | Organism | Action | References |
|---|---|---|---|---|
| 1 | BIMP082880 | Homo sapiens (human) | Cyclosporine results in increased expression of ABL2 mRNA | |
| 2 | BIMP082885 | Homo sapiens (human) | T-2 toxin results in decreased expression of ABL2 mRNA | |
| 3 | BIMP088120 | Homo sapiens (human) | Arsenite inhibits the reaction [G3BP1 protein binds to ABL2 mrna] | |
| 4 | BIMP090429 | Homo sapiens (human) | [INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA | |
| 5 | BIMP090429 | Homo sapiens (human) | [[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ABL2 mRNA | |
| 6 | BIMP090535 | Homo sapiens (human) | [estradiol co-treated with TGFB1 protein] results in increased expression of ABL2 mRNA | |
| 7 | BIMP090535 | Homo sapiens (human) | Estradiol results in increased expression of ABL2 mRNA | |
| 8 | BIMP019668 | Homo sapiens (human) | [INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA | |
| 9 | BIMP016724 | Homo sapiens (human) | [NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABL2 mRNA | |
| 10 | BIMP064420 | Homo sapiens (human) | Aflatoxin B1 results in increased methylation of ABL2 intron | |
| 11 | BIMP064420 | Homo sapiens (human) | Aflatoxin B1 results in increased expression of ABL2 mRNA | |
| 12 | BIMP063494 | Homo sapiens (human) | [[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ABL2 mRNA | |
| 13 | BIMP037097 | Homo sapiens (human) | Abrine results in increased expression of ABL2 mRNA | |
| 14 | BIMP037221 | Homo sapiens (human) | [dronabinol co-treated with cannabidiol] results in increased expression of ABL2 mRNA | |
| 15 | BIMP015441 | Homo sapiens (human) | Taurine results in increased expression of ABL2 mRNA | |
| 16 | BIMP065553 | Homo sapiens (human) | Theophylline results in decreased expression of ABL2 mRNA | |
| 17 | BIMP068008 | Homo sapiens (human) | Aristolochic acid I results in increased expression of ABL2 mRNA | |
| 18 | BIMP094273 | Homo sapiens (human) | [[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ABL2 mRNA | |
| 19 | BIMP093437 | Homo sapiens (human) | [dronabinol co-treated with cannabidiol] results in increased expression of ABL2 mRNA | |
| 20 | BIMP094060 | Homo sapiens (human) | [potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of ABL2 mRNA | |
| 21 | BIMP094169 | Homo sapiens (human) | [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of ABL2 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of ABL2 mRNA | |
| 22 | BIMP091110 | Homo sapiens (human) | Testosterone results in decreased expression of ABL2 mRNA | |
| 23 | BIMP103258 | Homo sapiens (human) | Benzo(e)pyrene results in increased methylation of ABL2 intron | |
| 24 | BIMP103343 | Homo sapiens (human) | [1-methylanthracene co-treated with fluoranthene] results in increased expression of ABL2 mRNA | |
| 25 | BIMP100631 | Homo sapiens (human) | [[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ABL2 mRNA | |
| 26 | BIMP100884 | Homo sapiens (human) | [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of ABL2 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of ABL2 mRNA | |
| 27 | BIMP095241 | Homo sapiens (human) | Ethanol affects the splicing of ABL2 mRNA | |
| 28 | BIMP094851 | Homo sapiens (human) | Xylitol results in increased expression of ABL2 mRNA | |
| 29 | BIMP094590 | Homo sapiens (human) | Dopamine results in decreased expression of ABL2 mRNA | |
| 30 | BIMP094277 | Homo sapiens (human) | Bisphenol A affects the expression of ABL2 mRNA | |
| 31 | BIMP094277 | Homo sapiens (human) | [[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ABL2 mRNA | |
| 32 | BIMP094277 | Homo sapiens (human) | Bisphenol A affects the expression of ABL2 mRNA | |
| 33 | BIMP094277 | Homo sapiens (human) | Bisphenol A results in decreased expression of ABL2 mRNA | |
| 34 | BIMP094277 | Homo sapiens (human) | Bisphenol A results in increased expression of ABL2 mRNA | |
| 35 | BIMP068482 | Homo sapiens (human) | Benzo(a)pyrene affects the methylation of ABL2 intron | |
| 36 | BIMP068482 | Homo sapiens (human) | Benzo(a)pyrene results in increased methylation of ABL2 promoter|benzo(a)pyrene results in decreased methylation of ABL2 3' UTR | |
| 37 | BIMP070286 | Homo sapiens (human) | Caffeine results in decreased phosphorylation of ABL2 protein | |
| 38 | BIMP072381 | Homo sapiens (human) | Coumarin affects the phosphorylation of ABL2 protein | |
| 39 | BIMP072777 | Homo sapiens (human) | Gentamicins results in increased expression of ABL2 mRNA | |
| 40 | BIMP073152 | Homo sapiens (human) | [INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA | |
| 41 | BIMP073586 | Homo sapiens (human) | Deoxynivalenol results in increased expression of ABL2 mRNA | |
| 42 | BIMP073605 | Homo sapiens (human) | [permethrin co-treated with DEET] results in increased methylation of ABL2 gene | |
| 43 | BIMP070955 | Homo sapiens (human) | Butyraldehyde results in increased expression of ABL2 mRNA | |
| 44 | BIMP072300 | Homo sapiens (human) | Doxorubicin results in decreased expression of ABL2 mRNA | |
| 45 | BIMP072198 | Homo sapiens (human) | Valproic acid results in decreased expression of ABL2 mrna|valproic acid affects the splicing of ABL2 mRNA | |
| 46 | BIMP071726 | Homo sapiens (human) | Diclofenac affects the expression of ABL2 mRNA |